Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edgio, Inc. - Common Stock (NQ:EGIO)

1.110 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edgio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Recap: Edgio Q2 Earnings ↗
  Edgio (NASDAQ:EGIO) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Edgio reported an EPS of $0.07. 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Friday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're diving into all the latest stock market news with a breakdown of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
12 Information Technology Stocks Moving In Wednesday's After-Market Session ↗
Gainers ClearSign Technologies (NASDAQ:CLIR) stock moved upwards by 6.8% to $1.26 during Wednesday's after-market session. The company's market cap stands at $45.7 million. 
Via Benzinga
News headline image
Why Is Fastly (FSLY) Stock Down 15% Today? ↗
FSLY stock is down big on an analyst downgrade, representing huge challenges for Fastly and the content delivery network sector. 
Via InvestorPlace
News headline image
12 Information Technology Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.